Mayfair Advisory Group’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,189
Closed -$299K 155
2024
Q2
$299K Buy
+2,189
New +$304K 0.2% 97
2023
Q3
Sell
-1,345
Closed -$212K 125
2023
Q2
$212K Sell
1,345
-222
-14% -$35.8K 0.21% 111
2023
Q1
$248K Sell
1,567
-605
-28% -$90.7K 0.27% 93
2022
Q4
$310K Buy
2,172
+125
+6% +$17.7K 0.39% 74
2022
Q3
$266K Buy
2,047
+75
+4% +$10.8K 0.38% 76
2022
Q2
$280K Buy
1,972
+401
+26% +$57.3K 0.37% 82
2022
Q1
$224K Buy
+1,571
New +$241K 0.29% 96

Other funds holding CLX

Mayfair Advisory Group's CLX Position: Q3 2024 in Review

Mayfair Advisory Group sold out of Clorox (CLX) in Q3 2024, closing a stake of 2,189 shares — an estimated $299K sold.

Mayfair Advisory Group first reported a position in CLX in Q1 2022 and held it in 7 quarters. The position peaked at $310K in Q4 2022. 1,151 funds tracked by Wall St. Rank hold CLX as of Q3 2024.

  • Mayfair Advisory Group reported no remaining Clorox position as of Q3 2024 after selling out during the quarter.
  • Mayfair Advisory Group sold 2,189 Clorox shares in Q3 2024, an estimated $299K.
  • Mayfair Advisory Group first reported a position in Clorox in Q1 2022 and held it in 7 quarters.
  • Mayfair Advisory Group's Clorox position peaked at $310K in Q4 2022.
  • 1,151 funds tracked by Wall St. Rank held Clorox as of Q3 2024.

Based on Mayfair Advisory Group's 13F filing for Q3 2024, filed 23 Oct 2024.